535 related articles for article (PubMed ID: 12820704)
1. Mutation analysis in congenital Long QT Syndrome--a case with missense mutations in KCNQ1 and SCN5A.
Paulussen A; Matthijs G; Gewillig M; Verhasselt P; Cohen N; Aerssens J
Genet Test; 2003; 7(1):57-61. PubMed ID: 12820704
[TBL] [Abstract][Full Text] [Related]
2. [A novel KCNQ1 mutation in Chinese with congenital long QT syndrome].
Liang L; Du ZD; Cai LL; Wu JX; Zheng T; Qi TX
Zhonghua Er Ke Za Zhi; 2003 Oct; 41(10):724-7. PubMed ID: 14731347
[TBL] [Abstract][Full Text] [Related]
3. KCNQ1 and KCNH2 mutations associated with long QT syndrome in a Chinese population.
Liu W; Yang J; Hu D; Kang C; Li C; Zhang S; Li P; Chen Z; Qin X; Ying K; Li Y; Li Y; Li Z; Cheng X; Li L; Qi Y; Chen S; Wang Q
Hum Mutat; 2002 Dec; 20(6):475-6. PubMed ID: 12442276
[TBL] [Abstract][Full Text] [Related]
4. Long QT and Brugada syndrome gene mutations in New Zealand.
Chung SK; MacCormick JM; McCulley CH; Crawford J; Eddy CA; Mitchell EA; Shelling AN; French JK; Skinner JR; Rees MI
Heart Rhythm; 2007 Oct; 4(10):1306-14. PubMed ID: 17905336
[TBL] [Abstract][Full Text] [Related]
5. Novel KCNQ1 and HERG missense mutations in Dutch long-QT families.
Jongbloed RJ; Wilde AA; Geelen JL; Doevendans P; Schaap C; Van Langen I; van Tintelen JP; Cobben JM; Beaufort-Krol GC; Geraedts JP; Smeets HJ
Hum Mutat; 1999; 13(4):301-10. PubMed ID: 10220144
[TBL] [Abstract][Full Text] [Related]
6. A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics.
Piippo K; Swan H; Pasternack M; Chapman H; Paavonen K; Viitasalo M; Toivonen L; Kontula K
J Am Coll Cardiol; 2001 Feb; 37(2):562-8. PubMed ID: 11216980
[TBL] [Abstract][Full Text] [Related]
7. DHPLC analysis of potassium ion channel genes in congenital long QT syndrome.
Jongbloed R; Marcelis C; Velter C; Doevendans P; Geraedts J; Smeets H
Hum Mutat; 2002 Nov; 20(5):382-91. PubMed ID: 12402336
[TBL] [Abstract][Full Text] [Related]
8. Hypokalemia-induced long QT syndrome with an underlying novel missense mutation in S4-S5 linker of KCNQ1.
Kubota T; Shimizu W; Kamakura S; Horie M
J Cardiovasc Electrophysiol; 2000 Sep; 11(9):1048-54. PubMed ID: 11021476
[TBL] [Abstract][Full Text] [Related]
9. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.
Paulussen AD; Gilissen RA; Armstrong M; Doevendans PA; Verhasselt P; Smeets HJ; Schulze-Bahr E; Haverkamp W; Breithardt G; Cohen N; Aerssens J
J Mol Med (Berl); 2004 Mar; 82(3):182-8. PubMed ID: 14760488
[TBL] [Abstract][Full Text] [Related]
10. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
Tester DJ; Will ML; Haglund CM; Ackerman MJ
Heart Rhythm; 2005 May; 2(5):507-17. PubMed ID: 15840476
[TBL] [Abstract][Full Text] [Related]
11. Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.
Antzelevitch C
J Electrocardiol; 2001; 34 Suppl():177-81. PubMed ID: 11781953
[TBL] [Abstract][Full Text] [Related]
12. Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population.
Allan WC; Timothy K; Vincent GM; Palomaki GE; Neveux LM; Haddow JE
J Med Screen; 2001; 8(4):173-7. PubMed ID: 11743032
[TBL] [Abstract][Full Text] [Related]
13. Four potassium channel mutations account for 73% of the genetic spectrum underlying long-QT syndrome (LQTS) and provide evidence for a strong founder effect in Finland.
Fodstad H; Swan H; Laitinen P; Piippo K; Paavonen K; Viitasalo M; Toivonen L; Kontula K
Ann Med; 2004; 36 Suppl 1():53-63. PubMed ID: 15176425
[TBL] [Abstract][Full Text] [Related]
14. Compound heterozygosity for mutations Asp611-->Tyr in KCNQ1 and Asp609-->Gly in KCNH2 associated with severe long QT syndrome.
Yamaguchi M; Shimizu M; Ino H; Terai H; Hayashi K; Kaneda T; Mabuchi H; Sumita R; Oshima T; Hoshi N; Higashida H
Clin Sci (Lond); 2005 Feb; 108(2):143-50. PubMed ID: 15500450
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of two founder mutations causing long QT syndrome and identification of compound heterozygous patients.
Fodstad H; Bendahhou S; Rougier JS; Laitinen-Forsblom PJ; Barhanin J; Abriel H; Schild L; Kontula K; Swan H
Ann Med; 2006; 38(4):294-304. PubMed ID: 16754261
[TBL] [Abstract][Full Text] [Related]
16. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance.
Barc J; Briec F; Schmitt S; Kyndt F; Le Cunff M; Baron E; Vieyres C; Sacher F; Redon R; Le Caignec C; Le Marec H; Probst V; Schott JJ
J Am Coll Cardiol; 2011 Jan; 57(1):40-7. PubMed ID: 21185499
[TBL] [Abstract][Full Text] [Related]
17. [DNA-based diagnostics of long QT syndrome].
Berge KE; Haugaa KH; Anfinsen OG; Früh A; Hallerud M; Jonsrud C; Øyen N; Gjesdal K; Amlie JP; Leren TP
Tidsskr Nor Laegeforen; 2005 Oct; 125(20):2783-6. PubMed ID: 16244680
[TBL] [Abstract][Full Text] [Related]
18. [Gene mutation analysis of a Chinese family of congenital long Q-T syndrome type three].
Shi RM; Ma AQ; Zhang YM; Yang C; Huang C; Zhou XH; Liu XH
Zhonghua Er Ke Za Zhi; 2009 Dec; 47(12):926-30. PubMed ID: 20193146
[TBL] [Abstract][Full Text] [Related]
19. Clinical characteristics of patients with congenital long QT syndrome and bigenic mutations.
Jimmy JJ; Chen CY; Yeh HM; Chiu WY; Yu CC; Liu YB; Tsai CT; Lo LW; Yeh SF; Lai LP
Chin Med J (Engl); 2014; 127(8):1482-6. PubMed ID: 24762593
[TBL] [Abstract][Full Text] [Related]
20. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block.
Lupoglazoff JM; Cheav T; Baroudi G; Berthet M; Denjoy I; Cauchemez B; Extramiana F; Chahine M; Guicheney P
Circ Res; 2001 Jul; 89(2):E16-21. PubMed ID: 11463728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
